Steinert's Disease Clinical Trial
NCT number | NCT02930408 |
Other study ID # | STEINECHO |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | October 10, 2016 |
Last updated | October 11, 2016 |
Start date | January 2014 |
Steinert's disease is an orphan disease. The prognosis of patients with this disease is conditioned by cardiac involvement. Search an early stage alterations in contractile function in subjects suffering from dystrophy would detect patients at risk of sudden death. The first stage of work is to validate the tools to detect early stage of infringement systolic function in a population of patients with myotonic dystrophy.
Status | Terminated |
Enrollment | 70 |
Est. completion date | |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | |
Gender | Both |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - patients suffering from muscular dystrophy type 1 followed CHU Poitiers. - age = 18 years Exclusion Criteria: - duration QRS> 120 ms ECG permanent ventricular stimulation - trouble segmental kinetic obvious to echocardiography in visual analysis |
N/A
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Poitiers University Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ventricular Ejection Fraction Left 3D | Immediately | ||
Primary | Global longitudinal systolic Strain | Immediately | ||
Primary | Strain of the dispersion index | Immediately |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00082108 -
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
|
||
Not yet recruiting |
NCT05532813 -
Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
|
Phase 3 | |
Recruiting |
NCT02398786 -
Myotonic Dystrophy Family Registry
|